NO316942B1 - Celle uttrykkende kimert reseptorprotein, samt DNA og vektor - Google Patents

Celle uttrykkende kimert reseptorprotein, samt DNA og vektor Download PDF

Info

Publication number
NO316942B1
NO316942B1 NO19960175A NO960175A NO316942B1 NO 316942 B1 NO316942 B1 NO 316942B1 NO 19960175 A NO19960175 A NO 19960175A NO 960175 A NO960175 A NO 960175A NO 316942 B1 NO316942 B1 NO 316942B1
Authority
NO
Norway
Prior art keywords
cell
cells
receptor
kinase
syk
Prior art date
Application number
NO19960175A
Other languages
English (en)
Norwegian (no)
Other versions
NO960175L (no
NO960175D0 (no
Inventor
Brian Seed
Charles Romeo
Waldemar Kolanus
Original Assignee
Gen Hospital Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gen Hospital Corp filed Critical Gen Hospital Corp
Publication of NO960175D0 publication Critical patent/NO960175D0/no
Publication of NO960175L publication Critical patent/NO960175L/no
Publication of NO316942B1 publication Critical patent/NO316942B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1205—Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70514—CD4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Genetics & Genomics (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • AIDS & HIV (AREA)
  • Biotechnology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
NO19960175A 1993-07-16 1996-01-15 Celle uttrykkende kimert reseptorprotein, samt DNA og vektor NO316942B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US9321093A 1993-07-16 1993-07-16
PCT/US1994/006675 WO1995002686A1 (en) 1993-07-16 1994-06-14 Redirection of cellular immunity by receptor chimeras

Publications (3)

Publication Number Publication Date
NO960175D0 NO960175D0 (no) 1996-01-15
NO960175L NO960175L (no) 1996-03-15
NO316942B1 true NO316942B1 (no) 2004-07-05

Family

ID=22237762

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19960175A NO316942B1 (no) 1993-07-16 1996-01-15 Celle uttrykkende kimert reseptorprotein, samt DNA og vektor

Country Status (18)

Country Link
EP (1) EP0804552B1 (cs)
JP (2) JP3588115B2 (cs)
KR (1) KR100278352B1 (cs)
AT (1) ATE236973T1 (cs)
AU (2) AU686646B2 (cs)
CA (1) CA2166102C (cs)
CZ (1) CZ291754B6 (cs)
DE (1) DE69432487T2 (cs)
DK (1) DK0804552T3 (cs)
ES (1) ES2197166T3 (cs)
FI (1) FI119995B (cs)
HU (1) HU224137B1 (cs)
NO (1) NO316942B1 (cs)
NZ (1) NZ269312A (cs)
PT (1) PT804552E (cs)
RU (1) RU2158305C2 (cs)
WO (1) WO1995002686A1 (cs)
ZA (1) ZA945204B (cs)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6319494B1 (en) 1990-12-14 2001-11-20 Cell Genesys, Inc. Chimeric chains for receptor-associated signal transduction pathways
US6407221B1 (en) 1990-12-14 2002-06-18 Cell Genesys, Inc. Chimeric chains for receptor-associated signal transduction pathways
US5912170A (en) * 1991-03-07 1999-06-15 The General Hospital Corporation Redirection of cellular immunity by protein-tyrosine kinase chimeras
US7049136B2 (en) 1991-03-07 2006-05-23 The General Hospital Corporation Redirection of cellular immunity by receptor chimeras
US6004811A (en) 1991-03-07 1999-12-21 The Massachussetts General Hospital Redirection of cellular immunity by protein tyrosine kinase chimeras
US5851828A (en) 1991-03-07 1998-12-22 The General Hospital Corporation Targeted cytolysis of HIV-infected cells by chimeric CD4 receptor-bearing cells
US6753162B1 (en) 1991-03-07 2004-06-22 The General Hospital Corporation Targeted cytolysis of HIV-infected cells by chimeric CD4 receptor-bearing cells
US5837544A (en) * 1995-02-02 1998-11-17 Cell Genesys, Inc. Method of inducing a cell to proliferate using a chimeric receptor comprising janus kinase
US6103521A (en) * 1995-02-06 2000-08-15 Cell Genesys, Inc. Multispecific chimeric receptors
GB9526131D0 (en) * 1995-12-21 1996-02-21 Celltech Therapeutics Ltd Recombinant chimeric receptors
US5916771A (en) * 1996-10-11 1999-06-29 Abgenix, Inc. Production of a multimeric protein by cell fusion method
US6420140B1 (en) 1996-10-11 2002-07-16 Abgenix, Inc. Production of multimeric protein by cell fusion method
GB9809658D0 (en) * 1998-05-06 1998-07-01 Celltech Therapeutics Ltd Biological products
UY34807A (es) 2012-05-16 2013-12-31 Novartis Ag Derivados monocíclicos de heteroarilcicloalquil- diamina
MX2020009272A (es) 2018-03-06 2021-01-08 Univ Pennsylvania Receptores de antígeno quimérico del antígeno de membrana específico de próstata y métodos de uso de los mismos.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU1759873A1 (ru) * 1990-08-14 1992-09-07 Новосибирский государственный университет им.Ленинского комсомола Фрагмент дезоксирибонуклиновой кислоты, кодирующий промотор SP6 РНК-полимеразы
IE920716A1 (en) * 1991-03-07 1992-09-09 Gen Hospital Corp Redirection of cellular immunity by receptor chimeras
US5851828A (en) * 1991-03-07 1998-12-22 The General Hospital Corporation Targeted cytolysis of HIV-infected cells by chimeric CD4 receptor-bearing cells

Also Published As

Publication number Publication date
AU712245C (en) 2004-10-28
HU224137B1 (hu) 2005-05-30
KR100278352B1 (ko) 2001-01-15
CA2166102C (en) 2008-03-18
EP0804552A1 (en) 1997-11-05
AU7314094A (en) 1995-02-13
FI119995B (fi) 2009-05-29
CZ291754B6 (cs) 2003-05-14
JP3588115B2 (ja) 2004-11-10
HUT74252A (en) 1996-11-28
ATE236973T1 (de) 2003-04-15
NZ269312A (en) 1998-02-26
DE69432487D1 (de) 2003-05-15
NO960175L (no) 1996-03-15
EP0804552A4 (en) 1999-07-14
CA2166102A1 (en) 1995-01-26
JPH09500020A (ja) 1997-01-07
ES2197166T3 (es) 2004-01-01
WO1995002686A1 (en) 1995-01-26
JP2004222735A (ja) 2004-08-12
EP0804552B1 (en) 2003-04-09
FI960178L (fi) 1996-01-15
CZ340895A3 (en) 1996-08-14
AU712245B2 (en) 1999-11-04
FI960178A0 (fi) 1996-01-15
PT804552E (pt) 2003-08-29
AU6476798A (en) 1998-07-02
HU9600084D0 (en) 1996-03-28
AU686646B2 (en) 1998-02-12
JP3738024B2 (ja) 2006-01-25
ZA945204B (en) 1995-05-30
DK0804552T3 (da) 2003-07-28
RU2158305C2 (ru) 2000-10-27
DE69432487T2 (de) 2004-04-08
NO960175D0 (no) 1996-01-15

Similar Documents

Publication Publication Date Title
KR100454396B1 (ko) 단백질-티로신키나제키메라에의한세포면역성의방향전환
US6392013B1 (en) Redirection of cellular immunity by protein tyrosine kinase chimeras
CA2209300C (en) Redirection of cellular immunity by receptor chimeras
US7049136B2 (en) Redirection of cellular immunity by receptor chimeras
EP0574512B1 (en) Redirection of cellular immunity by receptor chimeras
NO316942B1 (no) Celle uttrykkende kimert reseptorprotein, samt DNA og vektor

Legal Events

Date Code Title Description
MK1K Patent expired